These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25695417)

  • 1. Alzheimer's disease and type 2 diabetes: what is the connection?
    Greene A; Ng J; Shepherd L; Carey K
    Consult Pharm; 2015 Feb; 30(2):112-5. PubMed ID: 25695417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rationale for Insulin Therapy in Alzheimer's Disease.
    Ribarič S
    Molecules; 2016 May; 21(6):. PubMed ID: 27240327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liraglutide in Alzheimer's disease pathology.
    Vargas-Soria M; Carranza-Naval MJ; Del Marco A; Garcia-Alloza M
    Alzheimers Res Ther; 2021 Jun; 13(1):112. PubMed ID: 34118986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
    Li X; Song D; Leng SX
    Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes.
    Subramanian S; John M
    Indian J Exp Biol; 2012 Jan; 50(1):41-4. PubMed ID: 22279939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin: an emerging treatment for Alzheimer's disease dementia?
    Morris JK; Burns JM
    Curr Neurol Neurosci Rep; 2012 Oct; 12(5):520-7. PubMed ID: 22791280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.
    Yang Y; Zhang J; Ma D; Zhang M; Hu S; Shao S; Gong CX
    J Alzheimers Dis; 2013; 37(3):637-48. PubMed ID: 23948890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New animal models of Alzheimer's disease that display insulin desensitization in the brain.
    Gao C; Liu Y; Li L; Hölscher C
    Rev Neurosci; 2013; 24(6):607-15. PubMed ID: 24259244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does insulin therapy for type 1 diabetes mellitus protect against Alzheimer's disease?
    Rdzak GM; Abdelghany O
    Pharmacotherapy; 2014 Dec; 34(12):1317-23. PubMed ID: 25280207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal insulin in Alzheimer's disease: Food for thought.
    Chapman CD; Schiöth HB; Grillo CA; Benedict C
    Neuropharmacology; 2018 Jul; 136(Pt B):196-201. PubMed ID: 29180222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
    Muñoz-Jiménez M; Zaarkti A; García-Arnés JA; García-Casares N
    Dement Geriatr Cogn Disord; 2020; 49(5):423-434. PubMed ID: 33080602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease.
    Hölscher C
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S33-7. PubMed ID: 24529523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and insulin resistance: translating basic science into clinical applications.
    De Felice FG
    J Clin Invest; 2013 Feb; 123(2):531-9. PubMed ID: 23485579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
    Akter K; Lanza EA; Martin SA; Myronyuk N; Rua M; Raffa RB
    Br J Clin Pharmacol; 2011 Mar; 71(3):365-76. PubMed ID: 21284695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.